Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Pfizer seeks EUA for omicron booster in young children
Pfizer and BioNTech are seeking an emergency use authorization from the FDA for omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.
Q&A: Providing personalized care for premature infants with bronchopulmonary dysplasia
Caring for premature babies with bronchopulmonary dysplasia, which is a serious lung condition that occurs in babies born very premature, requires individualized treatment plans.
Log in or Sign up for Free to view tailored content for your specialty!
Patients often misunderstand common medical phrases
Patients frequently misunderstand physician phrases and assign opposite meanings of what was intended, leading to confusion about health outcomes, a study published in JAMA Network Open reported.
Flu hospitalizations hit 12-year high for this time of year
Hospitalizations for influenza are the highest they have been at this time of year since 2010, the CDC reported Friday.
Zika exposure in womb may impact development into preschool age, study finds
Children who were exposed to Zika virus in utero may demonstrate developmental differences into preschool age, even if they did not have congenital Zika syndrome, according to a study published in Pediatric Research.
Some practices can benefit from a state tax strategy
Practices may find this short primer on state pass-through entity election and year-end tax tips helpful to determine whether they can benefit from a state tax strategy or create some tax savings before Jan. 1, 2023.
Undernutrition before TB, after treatment initiation associated with adverse outcomes
Undernutrition, both before tuberculosis onset and at treatment initiation, as well as a lack of body mass index increase after intensive therapy, are associated with unfavorable TB outcomes, according to a recent study.
Q&A: Investigational therapy shows potential for treating patients with IPF
Saracatinib appeared to be “equal or superior” in stopping fibrotic responses compared with two FDA-approved antifibrotic drugs, according to a preclinical study published in American Journal of Respiratory and Critical Care Medicine.
Factor Xa inhibitor use linked to risk for ILD in patients with atrial fibrillation
In patients with nonvalvular atrial fibrillation receiving oral anticoagulants, factor Xa inhibitors appeared associated with increased risk for interstitial lung disease, according to a study published in JAMA Network Open.
Paxlovid associated with decreased hospitalization among adults with COVID-19
New data published in an MMWR report showed that patients with COVID-19 given a prescription for Paxlovid had a lower rate of hospitalization.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read